Global Smart Biopsy Devices Market 2024 - Opportunity Analysis, Industry Trends, Business Segmentation And Forecast To 2033

The new report published by The Business Research Company, titled Smart Biopsy Devices Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the smart biopsy devices market size has grown strongly in recent years. It will grow from $2.73 billion in 2023 to $2.93 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12271&type=smp

Surging Cancer Cases To Drive Market Growth
The rising cancer cases are expected to propel the growth of the smart biopsy devices market going forward. Cancer is a broad category of illnesses that can develop in nearly any organ or tissue in the body when aberrant cells proliferate uncontrollably, cross their usual boundaries, and either spread to other organs or invade neighboring body parts. The rising number of cancer cases increased the need for precise and focused tissue samples. This has sparked the creation and advancement of smart biopsy instruments with better molecular, imaging, and precision capabilities to aid diagnosis and treatment planning. For instance, in October 2022, according to the Australian Institute of Health and Welfare, an Australia-based government agency, in 2021, 1.58 million new cancer cases were diagnosed in Australia, an increase from 1.54 million new cancer cases in 2020. Therefore, the rising cancer cases are driving the growth of the smart biopsy device market.

Technological Innovations Transforming The Smart Biopsy Devices Market
Technological innovation has emerged as a key trend gaining popularity in the smart biopsy devices market. Major companies operating in the smart biopsy device market are concentrating on creating innovative products to strengthen their position in the market. For instance, in April 2021, IZI Medical Products LLC, a US-based medical devices company, launched the Quick-Core Auto Biopsy System (Quick-Core Auto Technology) for soft tissue biopsy. It is portable, utterly automatic biopsy equipment that builds on the success of IZI's semi-automatic Quick-Core biopsy gadget. It provides the same level of dependability, accuracy, and quality. The Quick-Core Biopsy Needle is lightweight and compact, allowing one-handed use during procedures.

The smart biopsy devices market covered in this report is segmented -

1) By Product: Needle-Based Biopsy Instruments, Procedure trays, Localization Wires, Other Products
2) By Guidance Technique: Ultrasound-Guided Biopsy, Stereotactic-Guided Biopsy, Magnetic Resonance Imaging-Guided Biopsy, Other Guidance Techniques
3) By Application: Breast Cancer, Skin Cancer, Liver Cancer, Prostate Cancer, Other Applications
4) By End-User: Hospitals, Academic And Research Institutes, Diagnostic And Imaging Centers

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12271&type=discount

Major companies operating in the smart biopsy devices market report are Cardinal Health Inc, General Electric Company, Medtronic Plc, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., ZAMAR CARE, DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

Contents of the report:
1. Executive Summary
2. Smart Biopsy Devices Market Report Structure
3. Smart Biopsy Devices Market Trends And Strategies
4. Smart Biopsy Devices Market - Macro Economic Scenario
5. Smart Biopsy Devices Market Size And Growth
…..
27. Smart Biopsy Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.